Serological Status of Epstein-Barr Virus in Bone Marrow Donor and Recipient and its Impact on Post-Transplant Outcomes

Ana Vitória Magalhães Chaves

doi:10.47363/jtmtr/2025(4)116

June 30, 2025

Serological Status of Epstein-Barr Virus in Bone Marrow Donor and Recipient and its Impact on Post-Transplant Outcomes

View at Publisher

Ask AI

Bookmark

Share

Key Points

EBV serological status significantly influences post-transplant outcomes, affecting recipient recovery.
Among bone marrow recipients, the presence of EBV can lead to complications and affect overall health.
Assessment of EBV serological status in donors is crucial for improving transplant success rates.
Understanding the relationship between EBV and B lymphocytes can aid in enhancing post-transplant care.

Implication

Observational analysis examines EBV serological status affecting post-transplant outcomes in donors and recipients.

Abstract

The Epstein-Barr Virus (EBV) is a highly immunogenic herpesvirus that infects more than 90% of healthy individuals and can remain latent in B lymphocytes for years.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ana Vitória Magalhães Chaves (2025) studied this question.

synapsesocial.com/papers/68c18c089b7b07f3a061495d https://doi.org/10.47363/jtmtr/2025(4)116

View at Publisher

Ask AI

Bookmark

Share

Serological Status of Epstein-Barr Virus in Bone Marrow Donor and Recipient and its Impact on Post-Transplant Outcomes

Key Points

Implication

Abstract

Discussion

Cite This Study

Serological Status of Epstein-Barr Virus in Bone Marrow Donor and Recipient and its Impact on Post-Transplant Outcomes

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

Keep reading

More related papers